Drug Shortage Report for APO-LITHIUM CARBONATE
Report ID | 17254 |
Drug Identification Number | 02242838 |
Brand name | APO-LITHIUM CARBONATE |
Common or Proper name | LITHIUM CARBONATE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | LITHIUM CARBONATE |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | N05AN |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-09-08 |
Actual start date | 2017-08-15 |
Estimated end date | 2017-11-06 |
Actual end date | 2017-10-30 |
Shortage status | Resolved |
Updated date | 2017-10-31 |
Company comments | APO-LITHIUM CARBONATE 300 MG CAP 1000BTL available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2017-10-31 | French | Compare |
v11 | 2017-10-31 | English | Compare |
v10 | 2017-10-24 | French | Compare |
v9 | 2017-10-24 | English | Compare |
v8 | 2017-09-22 | French | Compare |
v7 | 2017-09-22 | English | Compare |
v6 | 2017-08-21 | French | Compare |
v5 | 2017-08-21 | English | Compare |
v4 | 2017-08-16 | French | Compare |
v3 | 2017-08-16 | English | Compare |
v2 | 2017-07-26 | French | Compare |
v1 | 2017-07-26 | English | Compare |
Showing 1 to 12 of 12